Clinical trial Recruiting at 1 site Interventional Ages 18 to 89

Can a handheld nebulizer compare with a lab device for citric acid cough tests in healthy adults?

Official title: Evaluating the Feasibility and Reliability of Using Handheld Nebulizers to Conduct Cough Sensitivity Testing With Citric Acid

Run by University of Montana · NCT07531901 · Data updated 2026-11-12

We’re testing if a cheap handheld nebulizer can reliably measure cough sensitivity the same way as a standard lab device in healthy adults.

Quick facts

Study typeInterventional
Ages18 Years to 89 Years
SexAll
Enrollment10 (estimated)
SponsorUniversity of Montana
Academic / other
Locations1 site (Missoula, Montana)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedFebruary 1, 2027
Study endsFebruary 28, 2027
Registry record updatedJuly 20, 2026
Trial IDNCT07531901 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults 18 years or older who consent to recording and meet spirometry criteria (FEV1/FVC ≥ 0.70) on the day of testing.

Probably not a fit

Individuals with current respiratory infections, chronic pulmonary diseases, or recent smoking (within six months) may not benefit from this testing approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares two methods for delivering citric acid to trigger coughs: a dosimeter-controlled lab nebulizer and a low-cost handheld nebulizer. Healthy adults will undergo standardized cough challenge testing with both systems, and cough thresholds (C2 and C5) will be compared to assess concordance and repeatability. The goal is to determine if handheld technology can provide reliable, accessible objective cough measurements outside specialized laboratories. The trial is a proof-of-concept and may inform broader use of handheld devices in outpatient or community settings.

Why it matters

Potential benefit: If successful, clinicians could use affordable handheld nebulizers to objectively assess cough sensitivity, increasing access to this testing outside specialized labs.

How similar studies have gone: Previous work has shown that alternative aerosol delivery methods can influence cough thresholds, but this study directly evaluates a low-cost handheld device against a standard lab system.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy adults at least 18 years of age
* Consent to audio/video recording of the research sessions for research purposes
* Spirometry testing results obtained by study team on same day of first testing session with FEV1/FVC ratio and FEV1 percent predicted values of at least 0.70

Exclusion Criteria:

* Pregnant or trying to become pregnant (if capable of becoming pregnant- a urine pregnancy test will be provided onsite and a negative result must be obtained prior to the first testing session)
* Smoking of any substance in the last six months
* Diagnosed or suspected pulmonary disease (e.g., asthma, COPD)
* History of chronic cough
* History of head or neck cancer
* History of neurological disease (e.g., cerebrovascular accident)
* History of dysphagia (swallowing difficulty)
* Current complaint of a voice problem
* Current upper respiratory infection

Where it's running

  • University of Montana
    Missoula, Montana, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.